BlueBox Precision Medicine Fund S
LU2519375591
BlueBox Precision Medicine Fund S/ LU2519375591 /
NAV12/06/2024 |
Diferencia+4.4700 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
1,203.1500USD |
+0.37% |
reinvestment |
Equity
Worldwide
|
Fuchs Asset M. ▶ |
Estrategia de inversión
The main objective of the Fund is to seek to maximise total return.
The Fund invests globally with at least 85% of its total assets in the equity securities of companies whose predominant economic activity is in the pharmaceuticals, biotechnology and life science sectors. The overall investment strategy of the BlueBox Precision Medicine Fund is to seek out companies that will create value for the Shareholders from precision medicine: the multi-year trend of increasingly precise and targeted drug development in the pharmaceutical and biotechnology industries. The BlueBox Precision Medicine Fund will typically hold 25 to 45 positions. The holding periods are expected to be generally long (multiple years) and turnover low, although at times the BlueBox Precision Medicine Fund may utilise shorter holding periods if value is realised more quickly or unexpected events occur.
Objetivo de inversión
The main objective of the Fund is to seek to maximise total return.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
- |
Inicio del año fiscal: |
01/01 |
Última distribución: |
- |
Banco depositario: |
Northern Trust Global Services SE |
País de origen: |
Luxembourg |
Permiso de distribución: |
Germany, Switzerland |
Gestor de fondo: |
Mark Dainty |
Volumen de fondo: |
15.86 millones
USD
|
Fecha de fundación: |
01/03/2023 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
5.00% |
Max. Comisión de administración: |
1.00% |
Inversión mínima: |
100,000.00 USD |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
- |
Sociedad de fondos
Fondos de empresa: |
Fuchs Asset M. |
Dirección: |
49,boulevard Prince Henri, 1724, Luxembourg |
País: |
Luxembourg |
Internet: |
info@fuchsgroup.com
|
Activos
Stocks |
|
98.20% |
Cash and Other Assets |
|
1.80% |
Países
United States of America |
|
72.40% |
United Kingdom |
|
6.00% |
Belgium |
|
5.90% |
France |
|
5.30% |
Switzerland |
|
3.10% |
Italy |
|
3.00% |
Denmark |
|
2.50% |
Otros |
|
1.80% |
Sucursales
Pharma/Biotechnology |
|
64.90% |
Pharma, production |
|
3.00% |
Cash / other assets |
|
1.80% |
Otros |
|
30.30% |